Profile data is unavailable for this security.
About the company
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
- Revenue in USD (TTM)54.14m
- Net income in USD-49.83m
- Incorporated2020
- Employees207.00
- LocationAVITA Medical Inc28159 Avenue Stanford, Suite 220VALENCIA 91355United StatesUSA
- Phone+1 (661) 367-9170
- Websitehttps://www.avitamedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. | 182.02m | -10.93m | 269.88m | 203.00 | -- | 0.4974 | -- | 1.48 | -0.1886 | -0.1886 | 3.15 | 9.31 | 0.2815 | 9.96 | 4.82 | 896,660.10 | -1.69 | 6.61 | -1.97 | 7.62 | 93.03 | 90.55 | -6.00 | 15.18 | 4.67 | -- | 0.00 | 0.00 | -24.27 | -0.0496 | -60.02 | -36.96 | -56.77 | -- |
Rezolute Inc | 0.00 | -68.46m | 272.97m | 59.00 | -- | 2.17 | -- | -- | -1.33 | -1.33 | 0.00 | 2.27 | 0.00 | -- | -- | 0.00 | -53.39 | -50.36 | -56.66 | -53.25 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.19 | -- | -- | -- |
Nkarta Inc | 0.00 | -107.91m | 276.59m | 150.00 | -- | 0.6103 | -- | -- | -2.01 | -2.01 | 0.00 | 6.42 | 0.00 | -- | -- | 0.00 | -21.95 | -32.39 | -23.07 | -34.05 | -- | -- | -- | -372,519.20 | -- | -- | 0.00 | -- | -- | -- | -3.22 | -- | 106.05 | -- |
Editas Medicine Inc | 67.03m | -193.45m | 278.77m | 265.00 | -- | 1.20 | -- | 4.16 | -2.36 | -2.36 | 0.8183 | 2.81 | 0.1447 | -- | 52.99 | 252,954.70 | -41.75 | -29.85 | -48.49 | -33.19 | -- | -- | -288.59 | -347.71 | -- | -- | 0.00 | -- | 296.32 | 19.59 | 30.49 | -- | -0.1477 | -- |
Zura Bio Ltd | 0.00 | -27.94m | 279.33m | 14.00 | -- | 1.78 | -- | -- | -0.4944 | -0.4944 | 0.00 | 2.46 | 0.00 | -- | -- | 0.00 | -23.00 | -- | -30.30 | -- | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -2,050.99 | -- | -- | -- |
Akebia Therapeutics Inc | 174.50m | -40.44m | 279.68m | 167.00 | -- | -- | -- | 1.60 | -0.2024 | -0.2024 | 0.8803 | -0.1608 | 0.7364 | 1.36 | 7.07 | 1,044,892.00 | -17.07 | -37.42 | -29.47 | -56.00 | 82.59 | 69.13 | -23.18 | -82.25 | 0.8222 | -4.41 | 8.89 | -- | -33.46 | -1.30 | 44.89 | -- | -- | -- |
Abeona Therapeutics Inc | 0.00 | -52.60m | 279.81m | 84.00 | -- | 3.67 | -- | -- | -2.13 | -2.13 | 0.00 | 1.76 | 0.00 | -- | -- | 0.00 | -56.09 | -53.22 | -65.23 | -65.81 | -- | -- | -- | -1,894.25 | -- | -- | 0.2004 | -- | 147.52 | 3.14 | -24.63 | -- | -55.74 | -- |
AVITA Medical Inc | 54.14m | -49.83m | 281.21m | 207.00 | -- | 11.74 | -- | 5.19 | -1.95 | -1.95 | 2.12 | 0.9216 | 0.6217 | 1.46 | 7.23 | 261,541.10 | -57.22 | -- | -68.00 | -- | 86.80 | -- | -92.04 | -- | 4.81 | -13.95 | 0.6315 | -- | 45.68 | -- | -32.69 | -- | -- | -- |
Alto Neuroscience Inc | -100.00bn | -100.00bn | 281.72m | 78.00 | -- | 1.57 | -- | -- | -- | -- | -- | 6.67 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.053 | -- | -- | -- | -31.02 | -- | -- | -- |
Design Therapeutics Inc | 0.00 | -50.53m | 283.10m | 57.00 | -- | 1.08 | -- | -- | -0.8982 | -0.8982 | 0.00 | 4.61 | 0.00 | -- | -- | 0.00 | -17.39 | -- | -17.96 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.61 | -- | -- | -- |
Lexeo Therapeutics Inc | 0.00 | -77.22m | 286.31m | 58.00 | -- | 1.74 | -- | -- | -2.81 | -2.81 | 0.00 | 4.99 | 0.00 | -- | -- | 0.00 | -60.10 | -- | -68.82 | -- | -- | -- | -- | -- | -- | -- | 0.0097 | -- | -100.00 | -- | -12.01 | -- | -- | -- |
Ocugen Inc | 8.19m | -45.87m | 290.74m | 65.00 | -- | 15.36 | -- | 35.49 | -0.1785 | -0.1785 | 0.0319 | 0.0658 | 0.1265 | -- | -- | 126,015.40 | -78.54 | -83.56 | -103.70 | -97.79 | -- | -- | -620.91 | -2,921.94 | -- | -- | 0.1445 | -- | 142.60 | -- | 27.33 | -- | 39.08 | -- |
Tscan Therapeutics Inc | 12.20m | -104.41m | 291.89m | 175.00 | -- | 1.14 | -- | 23.93 | -1.05 | -1.05 | 0.1225 | 4.82 | 0.0353 | -- | -- | 79,220.78 | -30.19 | -- | -33.78 | -- | -- | -- | -855.84 | -- | -- | -- | 0.1066 | -- | 55.52 | -- | -34.73 | -- | -- | -- |
Atea Pharmaceuticals Inc | 0.00 | -176.00m | 292.10m | 75.00 | -- | 0.613 | -- | -- | -2.10 | -2.10 | 0.00 | 5.64 | 0.00 | -- | -- | 0.00 | -30.97 | -5.90 | -32.19 | -6.98 | -- | -- | -- | -38.91 | -- | -- | 0.00 | -- | -- | -- | -17.30 | -- | -- | -- |
enGene Holdings Inc | 0.00 | -123.44m | 293.15m | 33.00 | -- | 1.27 | -- | -- | -4.77 | -4.77 | 0.00 | 5.21 | 0.00 | -- | -- | 0.00 | -78.13 | -- | -84.20 | -- | -- | -- | -- | -- | -- | -3.14 | 0.0906 | -- | -- | -- | -260.87 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.62m | 6.29% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.36m | 5.27% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 941.04k | 3.65% |
Geode Capital Management LLCas of 30 Jun 2024 | 586.08k | 2.27% |
AWM Investment Co., Inc.as of 31 Mar 2024 | 496.95k | 1.93% |
Silvercrest Asset Management Group LLCas of 31 Mar 2024 | 241.67k | 0.94% |
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 214.26k | 0.83% |
CenterBook Partners LPas of 31 Mar 2024 | 145.35k | 0.56% |
AQR Capital Management LLCas of 31 Mar 2024 | 90.60k | 0.35% |
GlobeFlex Capital LPas of 31 Mar 2024 | 76.86k | 0.30% |